Dipeptidyl peptidase IV (DP-IV) compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8563517
APP PUB NO 20110183919A1
SERIAL NO

13063691

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to novel compounds of formula I and pharmaceutically acceptable salts, enantiomers thereof having inhibiting properties of dipeptidyl peptidase IV enzyme (DP-IV inhibitors). The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds along with its composition in the prevention or treatment of diseases associated with DP-IV enzyme.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CADILA PHARMACEUTICALS LTDCADILA CORPORATE CAMPUS SARKHEJ-DHOLKA RD BHAT AHMEDABAD 382210

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chandan, Singh Ahmedabad, IN 2 0
Khamar, Bakulesh Mafatlal Ahmedabad, IN 34 81
Modi, Rajiv Indravadan Ahmedabad, IN 15 25

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 22, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00